Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Selegiline hydrochloride |
Is a |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing selegiline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline measurement (procedure) |
Component |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental selegiline poisoning |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional selegiline poisoning |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la sélégiline d'intention indéterminée |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline adverse reaction (disorder) |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to selegiline (finding) |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Selegiline overdose |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental selegiline overdose |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional selegiline overdose |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de sélégiline d'intention indéterminée |
Causative agent (attribute) |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional selegiline poisoning |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline 6mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Selegiline 9mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Selegiline 12mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to selegiline (finding) |
Causative agent (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline hydrochloride |
Is modification of (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Selegiline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline only product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 500 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 500 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 375 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has precise active ingredient |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely selegiline 375 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has basis of strength substance (attribute) |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Selegiline only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Selegiline (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |